Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Markel (MKL) Earnings And Revenues Miss Estimates In Q1

Published 05/03/2019, 08:39 AM
Updated 07/09/2023, 06:31 AM
US500
-
PGR
-
TRV
-
MKL
-
RLI
-

Markel Corporation (NYSE:MKL) reported first-quarter 2019 earnings of $9.24 per share, missing the Zacks Consensus Estimate by 1.8%. The bottom line declined 18.9% year over year.

The quarter witnessed solid performance in its investment portfolio, largely driven by favorable movements in the equity markets. Both underwriting and Markel Ventures operations delivered organic growth. The results included contributions from acquisitions of Brahmin, within the company’s Markel Ventures operations, and Nephila, within insurance-linked securities operations.

Operational Update

Total operating revenues of $1.7 billion missed the Zacks Consensus Estimate by 0.4%. The top line however rose 9.5% year over year on higher premiums, investment income, product and services plus other revenues.

Total operating expenses of Markel increased 14.1% year over year to $1.7 billion.

Markel’s combined ratio deteriorated 500 basis points (bps) year over year to 95% in the reported quarter.

Markel Corporation Price, Consensus and EPS Surprise

Segment Update

Insurance: Net written premiums were up 9.3% year over year to $998.4 million in the quarter under review.

Underwriting profit came in at $50.1 million that dropped 49% from the year-ago quarter.

Combined ratio deteriorated 600 bps year over year to 95% in the quarter under discussion.

Reinsurance: Net written premiums rose 13.8% year over year to $497 million.

Underwriting profit dropped 53% year over year to $3.4 million.

Combined ratio deteriorated 200 bps year over year to 99% in the first quarter.

Financial Update

Markel exited the first quarter with investments, cash and cash equivalents of $2.4 billion, up 19.9% from the level at year-end 2018.

Debt balance increased 1.6% to $3.1 billion as of Mar 31, 2019 from 2018 end.

Book value per share increased 8% from year-end 2018 to $706.98 as of Mar 31, 2019.

Net cash from operating activities was $18.7 million, down 67.5% year over year.

Zacks Rank

Markel currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Performance of Other Insurers

Among other players from the insurance industry that have reported first-quarter results so far, earnings of RLI Corp. (NYSE:RLI) , The Progressive Corporation (NYSE:PGR) and The Travelers Companies, Inc. (NYSE:TRV) topped the respective Zacks Consensus Estimate.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



The Travelers Companies, Inc. (TRV): Free Stock Analysis Report

The Progressive Corporation (PGR): Free Stock Analysis Report

RLI Corp. (RLI): Free Stock Analysis Report

Markel Corporation (MKL): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.